發送短信 : Cost-utility and budget impact analyses of gefitinib in second-line treatment for advanced non-small cell lung cancer from Thai payer perspective

  ____      _____                ___     _____    
 |  _ \\   |  ___||     ___     / _ \\  |  __ \\  
 | |_| ||  | ||__      /   ||  | / \ || | |  \ || 
 | .  //   | ||__     | [] ||  | \_/ || | |__/ || 
 |_|\_\\   |_____||    \__ ||   \___//  |_____//  
 `-` --`   `-----`      -|_||   `---`    -----`   
                         `-`